c-peptide and Hearing-Loss--Sensorineural

c-peptide has been researched along with Hearing-Loss--Sensorineural* in 1 studies

Other Studies

1 other study(ies) available for c-peptide and Hearing-Loss--Sensorineural

Article	Year
Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. Cells, 2021, 11-16, Volume: 10, Issue:11 Wolfram syndrome (WS), also known as a DIDMOAD (diabetes insipidus, early-onset diabetes mellitus, optic nerve atrophy and deafness) is a rare autosomal disorder caused by mutations in the Wolframin1 ( Topics: Animals; C-Peptide; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucagon-Like Peptide-1 Receptor; Hearing Loss, Sensorineural; Liraglutide; Male; Nerve Degeneration; Optic Nerve; Phenotype; Rats; Visual Pathways; Wolfram Syndrome	2021

Article

Year

Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype.

Cells, 2021, 11-16, Volume: 10, Issue:11

Wolfram syndrome (WS), also known as a DIDMOAD (diabetes insipidus, early-onset diabetes mellitus, optic nerve atrophy and deafness) is a rare autosomal disorder caused by mutations in the Wolframin1 (

Topics: Animals; C-Peptide; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucagon-Like Peptide-1 Receptor; Hearing Loss, Sensorineural; Liraglutide; Male; Nerve Degeneration; Optic Nerve; Phenotype; Rats; Visual Pathways; Wolfram Syndrome

2021